BioCentury | Apr 15, 2019
Distillery Therapeutics

MedImmune's bispecific mAb for Pseudomonas-related ocular keratitis

...CONTACT: Paul Kubes, University of Calgary, Calgary, Alta. email: pkubes@ucalgary.ca Sandi Wong MEDI3902, MEDI-3902 AstraZeneca plc MedImmune LLC University of Calgary Pseudomonas aeruginosa Psl exopolysaccharide (P. aeruginosa psl) Pseudomonas...
Items per page:
1 - 1 of 1